AIM MACROMED Ltd is an early-stage biotech start-up headquartered in London, UK. It is selected in the GBIP programme of Innovate UK.
Mission Statement: AIM MACROMED aims to radically transform biotech economy through value-add solutions using machine learning aided synthetic biology.

Brief profile of the company: AIM MACROMED is active in developing technology rooted in machine learning and synthetic biology for the following application areas:

A. Testbed & software to improve the efficiency of high-value chemical plants.

B. Testbed & software to produce added-value commodities using industrial waste.

C. Curated portfolio of software & methods for automated cloud labs – incl. apps.